Monday, March 8, 2021
wellness India Expo
Home Tags Psoriasis

Tag: psoriasis

Sun Pharma initiates Phase 2 clinical trial of Psoriasis drug

SCD-044 is also being evaluated in other autoimmune disorders and Phase 2 studies for other indications like atopic dermatitis, are also expected to be initiated soon......................

Sun Pharma announces 5-year sustained efficacy & safety results for its...

ILUMYA is the first IL-23 inhibitor to complete five years of study based on a pooled analysis of two Phase 3 efficacy and safety extension trials in moderate-to-severe plaque psoriasis.......................

Lupin & Mylan launch arthritis biosimilar, Nepexto in Germany

Nepexto is Lupin’s biosimilar etanercept approved for all indications of the reference product Enbrel. It is available as an injectable in an easy-to-use pre-filled pen and a pre-filled syringe...................

Sun Pharma seals US$ 145 million deal with SPARC over potential...

The two companies have announced a worldwide licensing agreement on the development and commercialization of SCD-044 which is being evaluated as a potential oral treatment for atopic dermatitis, psoriasis and other auto-immune disorders.............

Glenmark aims to transform the treatment for Psoriasis in India

Launches Apremilast, a revolutionary advanced oral treatment that addresses various limitations of the current therapies available in India................

Dr Reddy’s Labs out-licenses its psoriasis drug to Encore Dermatology

DFD-06, a topical high potency steroid is being commercialized in the United States market by Promius Pharma, LLC, the fully owned subsidiary of Dr Reddy's Lab..........

Sun Pharma achieves breaking results for its Psoriasis drug

The company has achieved primary end point in both Phase-3 studies in patients with moderate-to-severe plaque Psoriasis...

Novartis launches biologic treatment option for psoriasis

Scapho® (secukinumab) has been approved by the Drug Controller General of India (DCGI) for the treatment...